Axicabtagene Ciloleucel
ATC L01XL03 · 6 markets · 6 records
GB 1 records · 1 strengths
- 68 mLinjectionYescarta 40million-200million cells/68ml dispersion for infusion bags
CA 1 records · 1 strengths
- 200,000,000 cellsliquidYESCARTA
AU 1 records · 1 strengths
Records without a stated strength · 1 YESCARTA
CN 1 records · 1 strengths
- 68 mLinjection奕凯达阿基仑赛
TW 1 records · 1 strengths
Records without a stated strength · 1 YESCARTA suspension for intravenous infusion、悅卡達靜脈輸注用懸浮液
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 YESCARTA
| Strength / form / release | GB | CA | AU | CN | TW | EU |
|---|---|---|---|---|---|---|
| 68 mL injection | Yescarta 40million-200million cells/68ml dispersion for infusion bags | 奕凯达阿基仑赛 | ||||
| 200,000,000 cells check strength liquid | YESCARTA | |||||
injection | YESCARTA suspension for intravenous infusion 悅卡達靜脈輸注用懸浮液 | |||||
unknown | YESCARTA | YESCARTA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in GB · CN and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB · CN que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB · CN 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 GB · CN 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.